257 related articles for article (PubMed ID: 27912759)
1. Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation.
Raghunathan VM; Sheng I; Lim SH
J Transl Med; 2016 Dec; 14(1):335. PubMed ID: 27912759
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota and allogeneic transplantation.
Wang W; Xu S; Ren Z; Jiang J; Zheng S
J Transl Med; 2015 Aug; 13():275. PubMed ID: 26298517
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation.
Shono Y; van den Brink MRM
Nat Rev Cancer; 2018 May; 18(5):283-295. PubMed ID: 29449660
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota and acute graft-versus-host disease.
Yoshioka K; Kakihana K; Doki N; Ohashi K
Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
[TBL] [Abstract][Full Text] [Related]
5. Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation.
Schwabkey ZI; Jenq RR
Annu Rev Med; 2020 Jan; 71():137-148. PubMed ID: 31986084
[TBL] [Abstract][Full Text] [Related]
6. Intestinal microbiota-related effects on graft-versus-host disease.
Shono Y; Docampo MD; Peled JU; Perobelli SM; Jenq RR
Int J Hematol; 2015 May; 101(5):428-37. PubMed ID: 25812838
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
8. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.
Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T
J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171
[TBL] [Abstract][Full Text] [Related]
9. [Intestinal microbiota and allogeneic stem cell transplantation].
Dougé A; Bay JO; Ravinet A; Scanzi J
Bull Cancer; 2020 Jan; 107(1):72-83. PubMed ID: 31582175
[TBL] [Abstract][Full Text] [Related]
10. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
Kumari R; Palaniyandi S; Hildebrandt GC
Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
[TBL] [Abstract][Full Text] [Related]
11. Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation.
Andermann TM; Rezvani A; Bhatt AS
Curr Hematol Malig Rep; 2016 Feb; 11(1):19-28. PubMed ID: 26780719
[TBL] [Abstract][Full Text] [Related]
12. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
Shono Y
Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease.
van Lier YF; Vos J; Blom B; Hazenberg MD
Gut Microbes; 2023; 15(1):2178805. PubMed ID: 36794370
[TBL] [Abstract][Full Text] [Related]
14. Is it time to reconsider prophylactic antimicrobial use for hematopoietic stem cell transplantation? a narrative review of antimicrobials in stem cell transplantation.
Jahan D; Peile E; Sheikh MA; Islam S; Parasnath S; Sharma P; Iskandar K; Dhingra S; Charan J; Hardcastle TC; Samad N; Chowdhury TS; Dutta S; Haque M
Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1259-1280. PubMed ID: 33711240
[TBL] [Abstract][Full Text] [Related]
15. Changes in intestinal microbiota and their effects on allogeneic stem cell transplantation.
Shallis RM; Terry CM; Lim SH
Am J Hematol; 2018 Jan; 93(1):122-128. PubMed ID: 28842931
[TBL] [Abstract][Full Text] [Related]
16. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.
Staffas A; Burgos da Silva M; van den Brink MR
Blood; 2017 Feb; 129(8):927-933. PubMed ID: 27940475
[TBL] [Abstract][Full Text] [Related]
17. The gut microbiome: a clinically significant player in transplantation?
Vindigni SM; Surawicz CM
Expert Rev Clin Immunol; 2015; 11(7):781-3. PubMed ID: 26065325
[TBL] [Abstract][Full Text] [Related]
18. The post-hematopoietic cell transplantation microbiome: relationships with transplant outcome and potential therapeutic targets.
Van Lier YF; Van den Brink MRM; Hazenberg MD; Markey KA
Haematologica; 2021 Aug; 106(8):2042-2053. PubMed ID: 33882637
[TBL] [Abstract][Full Text] [Related]
19. Microbiome markers are early predictors of acute GVHD in allogeneic hematopoietic stem cell transplant recipients.
Greco R; Nitti R; Mancini N; Pasciuta R; Lorentino F; Lupo-Stanghellini MT; Barbanti MC; Clementi N; Giglio F; Clerici D; Marktel S; Assanelli A; Carrabba MG; Bernardi M; Corti C; Peccatori J; Clementi M; Ciceri F
Blood; 2021 Mar; 137(11):1556-1559. PubMed ID: 33171492
[No Abstract] [Full Text] [Related]
20. Impact of oral microbiota on pathophysiology of GVHD.
Yamamoto A; Kambara Y; Fujiwara H
Front Immunol; 2023; 14():1132983. PubMed ID: 36969182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
